Based on these findings, Zhao et al. suggested that PD-L1 functions as a protumorigenic factor and may serve as an important biomarker for HCC with microvascular invasion.49 Our results suggested that the presence of PD-L1-expressing CTCs in the portal vein was associated with poor outcomes. This evidence concerns the gene CD274 and hepatocellular carcinoma.